U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
148231148231Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma MultiformeActive, not recruitingNo Results AvailableBrain and Central Nervous System TumorsBiological: bevacizumab|Drug: sorafenib tosylatehttps://ClinicalTrials.gov/show/NCT00621686
148232148232Assessment of the Risk of Inhibitor Formation in Previously Treated Patients With Severe Hemophilia ATerminatedNo Results AvailableHemophilia ADrug: Kogenate (BAY 14-2222)https://ClinicalTrials.gov/show/NCT00621673
148233148233Acupuncture Versus Sham for Radiotherapy-Induced EmesisCompletedNo Results AvailableNausea|VomitingProcedure: Acupuncture|Procedure: Shamhttps://ClinicalTrials.gov/show/NCT00621660
148234148234Seroquel- Agitation Associated With DementiaCompletedNo Results AvailableAlzheimer's Disease|Vascular DementiaDrug: Quetiapine Fumarate|Drug: Quetiapine Fumarate|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00621647
148235148235Efficacy of Docosahexaenoic Acid on Tardive DyskinesiaRecruitingNo Results AvailableTardive DyskinesiaDietary Supplement: Omega-3 fish oil capsules (including DHA)|Dietary Supplement: Placebohttps://ClinicalTrials.gov/show/NCT00621634
148236148236CryoCath Freezor CryoAblation Catheter System (CRYOFACTS)CompletedHas ResultsTachycardia, Atrioventricular Nodal ReentryDevice: Freezor® Cardiac Cryoablation Catheter CryoConsole Systemhttps://ClinicalTrials.gov/show/NCT00621621
148237148237Hyperbaric Oxygen Therapy (HBOT) for Chronic Diabetic Lower Limb UlcersCompletedNo Results AvailableDiabetes Mellitus|Chronic Ulcers of the Lower LimbProcedure: Hyperbaric Oxygen Therapy|Procedure: Placebo Hyperbaric Oxygen Chamberhttps://ClinicalTrials.gov/show/NCT00621608
148238148238The Effects of Breakfast on Brain FunctionCompletedNo Results AvailableHealthyDietary Supplement: USDA School Breakfasthttps://ClinicalTrials.gov/show/NCT00621595
148239148239Spiriva® 18µg Once Daily in Chinese COPD Patients of Different Disease SeveritiesCompletedHas ResultsPulmonary Disease, Chronic Obstructivehttps://ClinicalTrials.gov/show/NCT00621582
148240148240ADAPT-Altering Diet for African American Populations to Treat HypertensionCompletedNo Results AvailableHypertensionBehavioral: Dietary Approaches to Stop Hypertension-The DASH diet|Behavioral: Intervention with no dietary component - information regarding useful life skillshttps://ClinicalTrials.gov/show/NCT00621569
148241148241Secretin Enhanced MRCP for Evaluation of the Known or Suspected Intraductal Papillary Mucinous Neoplasms of the PancreasTerminatedNo Results AvailableIntraductal Papillary Mucinous NeoplasmsDrug: RG1068 (Synthetic Human Secretin)https://ClinicalTrials.gov/show/NCT00621556
148242148242Insertion of an Intrauterine Device (IUD) After Medical AbortionCompletedHas ResultsIntrauterine Device Expulsion|Medical Abortion|Induced AbortionDevice: IUD insertion [Copper T-380A or Levonorgestrel (intrauterine system) IUS]https://ClinicalTrials.gov/show/NCT00621543
148243148243Effect of Spinal Ketorolac on Mechanical Hypersensitivity After a Total Hip ReplacementTerminatedNo Results AvailableHip ArthroplastyDrug: ketorolac tromethamine opthalmic solution|Drug: placebohttps://ClinicalTrials.gov/show/NCT00621530
148244148244Bupropion and Restless Legs SyndromeCompletedHas ResultsRestless Legs SyndromeDrug: Bupropion|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00621517
148245148245Comparative Study of Ceftaroline vs. Ceftriaxone in Adult Subjects With Community-Acquired PneumoniaCompletedHas ResultsBacterial PneumoniaDrug: Ceftaroline fosamil for Injection|Drug: IV Ceftriaxone|Drug: Placebo|Drug: Clarithromycinhttps://ClinicalTrials.gov/show/NCT00621504
148246148246Prevention of Venous Thrombosis After Permanent Transvenous Leads ImplantationCompletedNo Results AvailableCardiac Pacing|Complications|Venous ThrombosisDrug: Warfarinhttps://ClinicalTrials.gov/show/NCT00621491
148247148247Efficacy and Safety Study Comparing Lorazepam and Diazepam for Children in the Emergency Department With Seizures (Status 2)CompletedNo Results AvailableStatus EpilepticusDrug: lorazepam or diazepamhttps://ClinicalTrials.gov/show/NCT00621478
148248148248Critical Time Intervention in the Transition From Hospital to Community in People With Severe Mental IllnessCompletedNo Results AvailablePsychotic DisordersBehavioral: Critical Time Intervention (CTI)|Behavioral: Usual carehttps://ClinicalTrials.gov/show/NCT00621465
148249148249Genetically Engineered Lymphocytes, Cyclophosphamide, and Aldesleukin in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma or Indolent B-Cell Non-Hodgkin LymphomaCompletedNo Results AvailableB-cell Chronic Lymphocytic Leukemia|Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue|Nodal Marginal Zone B-cell Lymphoma|Recurrent Grade 1 Follicular Lymphoma|Recurrent Grade 2 Follicular Lymphoma|Recurrent Mantle Cell LymphomBiological: therapeutic autologous lymphocytes|Drug: cyclophosphamide|Biological: aldesleukin|Genetic: polymerase chain reaction|Genetic: gene rearrangement analysis|Procedure: lymph node biopsy|Biological: genetically engineered lymphocyte therapy|Procedure: bone marrow aspiration|Other: flow cytometry|Other: laboratory biomarker analysis|Other: enzyme-linked immunosorbent assayhttps://ClinicalTrials.gov/show/NCT00621452
148250148250Investigative Trial of Interferon Alpha-2b To Shrink Cancer of the EyeWithdrawnNo Results AvailableOcular MelanomaDrug: Pegylated Interfon Alpha 2B|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00621439
148251148251T-Wave Alternans in Dialysis PatientsCompletedNo Results AvailableSudden Cardiac Death|End Stage Renal Diseasehttps://ClinicalTrials.gov/show/NCT00621426
148252148252Observation of Outcomes and Side Effects of Cesium-131 in Combination With External Beam Radiation for the Treatment of Intermediate to High Risk Prostate CancerEnrolling by invitationNo Results AvailableProstate Cancerhttps://ClinicalTrials.gov/show/NCT00621413
148253148253Lenalidomide in Combination With Melphalan and Dexamethasone in Newly-diagnosed Light-chain (AL)-AmyloidosisCompletedNo Results AvailableAmyloidosisDrug: Lenalidomide|Drug: Melphalan|Drug: Dexamethasonehttps://ClinicalTrials.gov/show/NCT00621400
148254148254Study of Long-Term Antibiotic Treatment in Reactive ArthritisCompletedNo Results AvailableReactive ArthritisDrug: ofloxacin and roxithromycin|Drug: placebohttps://ClinicalTrials.gov/show/NCT00621387
148255148255Management of Pain in Persons With Multiple SclerosisCompletedNo Results AvailableMultiple Sclerosis|PainBehavioral: Cognitive Behavioral Therapy (CBT) +Hypnosis (HYP)|Behavioral: Cognitive Behavioral Therapy (CBT)|Behavioral: Self-Hypnosis Training (HYP)|Behavioral: Education Control (CONT)https://ClinicalTrials.gov/show/NCT00621374
148256148256Phase I Safety and Tolerability Study of Cediranib (RECENTINâ„¢, AZD2171) in Combination With Chemo in First Line Lung Cancer PatientsCompletedNo Results AvailableLung CancerDrug: AZD2171|Drug: Etoposide|Drug: Cisplatinhttps://ClinicalTrials.gov/show/NCT00621361
148257148257Maintenance Intravenous Fluids in ChildrenCompletedHas ResultsHyponatremiaDrug: Isotonic fluid|Drug: Hypotonic fluid|Drug: Hypotonic fluidhttps://ClinicalTrials.gov/show/NCT00621348
148258148258A Investigator Masked Parallel Comparison of Tolerability of Combigan and CosoptCompletedNo Results AvailableOpen Angle Glaucoma|Ocular Hypertensionhttps://ClinicalTrials.gov/show/NCT00621335
148259148259Safety and Immunogenicity Study of GSK Biologicals Tuberculosis Vaccines (692342) to Healthy AdultsCompletedNo Results AvailableTuberculosis (TB) InfectionBiological: Control vaccine with physiological saline|Biological: GSK Biologicals' Candidate Tuberculosis Vaccines (692342) - different formulations|Biological: Control vaccine with the adjuvant system.https://ClinicalTrials.gov/show/NCT00621322
148260148260Sulforaphane as an Antagonist to Human PXR-mediated Drug-drug InteractionsActive, not recruitingNo Results AvailableAdverse Drug InteractionsDrug: Rifampicin|Dietary Supplement: sulforaphane plus rifampicin|Dietary Supplement: sulforaphane alonehttps://ClinicalTrials.gov/show/NCT00621309

* Görseller ve İçerik tekif hakkına sahip olabilir